Search Results
Real-World PSA Response Data Similar to Clinical Trials in Prostate Cancer
Real-world PSA responses to apalutamide or enzalutamide in mCSPC
Comparing real world evidence to phase III data on apalutamide for nmCRPC
Dr. Benjamin Maughan on PSA Dynamics in Metastatic Prostate Cancer | ASCO 2024
Comparing Apalutamide and Enzalutamide in Real-World Treatment of mCSPC
ESOU Online: EAU22 highlights in prostate cancer
Dr. Freedland on Real-World Utility of Enzalutamide in Prostate Cancer
Using clinical trials in the real world
ASCO GU 2022 - ERLEADA ® Real-World Study in Metastatic Castration-Sensitive Prostate Cancer or mCS
Webinar - Beyond PSA: The ExoDx Prostate™ test (EPI) as a Precision Genomic Biomarker
Prostate Cancer in 2024: Recent Updates and Treatment Advances
Molecular and clinical characterization of mCRPC patients achieving deep PSA responses to BAT
